2008 | 2007 | 2006 | 2005 | 2004 | 2003

April 28, 2008

Institute for Clinical Systems Improvement

Diagnosis and treatment of otitis media in children: percentage of caregivers receiving education on the symptoms suggestive of otitis media, appropriate indicators for a provider visit, risk factors, and outcomes of otitis media. This updates a previously published measure summary.

Diagnosis and treatment of otitis media in children: percentage of patients with a diagnosis of acute otitis media who were prescribed amoxicillin. This updates a previously published measure summary.

Veterans Health Administration

Homeless: percent of eligible homeless veterans with an intake interview who receive timely MH or SUD specialty services. This updates a previously published measure summary.

Homeless: percent of homeless veterans entering a homeless program who receive timely MH or SUD specialty services. This updates a previously published measure summary.

Homeless: percent of homeless veterans entering a homeless residential program who receive timely primary care services. This updates a previously published measure summary.

Homeless: percent of veterans discharged from one of three types of homeless residential programs who receive timely MH or SUD specialty follow-up. This updates a previously published measure summary.

Mental Health Intensive Case Management (MHICM): percent of psychosis patients projected as requiring MHICM who receive outpatient care in MHICM. This updates a previously published measure summary.

Mental health: percent of patients beginning a new episode of treatment for substance use disorder (SUD) who maintain continuous treatment involvement for at least 90 days after qualifying date. This updates a previously published measure summary.

Waiting times - clinic: percent of outpatients seen in primary care at the facility in the previous 24 months who answer 'yes' to the question, "Did you get an appointment when you wanted one?" on the SHEP survey. This updates a previously published measure summary.

Waiting times - clinic: percent of outpatients who have not been seen in primary care at the facility in the previous 24 months who answer 'yes' to the question, "Did you get an appointment when you wanted one?" on the SHEP survey. This updates a previously published measure summary.

Waiting times - provider: percent of outpatients who report waiting for a provider 20 minutes or less in the Survey of Healthcare Experiences of Patients (SHEP). This updates a previously published measure summary.

April 21, 2008

Veterans Health Administration

Breast cancer screening: percent of women age 50 to 69 screened in the past two years for breast cancer. This updates a previously published measure summary.

Cervical cancer screening: percent of women age 21 to 64 screened for cervical cancer in the past three years. This updates a previously published measure summary.

Colon cancer screening: percent of patients receiving appropriate colorectal cancer screening. This updates a previously published measure summary.

Diabetes mellitus: percent of eligible patients with diabetes mellitus having a retinal exam by an Eye Care Specialist, timely, as indicated by disease. This updates a previously published measure summary.

Diabetes mellitus: percent of patients with a diagnosis of diabetes mellitus having hemoglobin A1c (HgbA1c) greater than 9 or not done during the past year. This updates a previously published measure summary.

Diabetes mellitus: percent of patients with a diagnosis of diabetes mellitus who have had a full lipid panel during the past year and the most recent LDL-C is less than 100 mg/dL. This updates a previously published measure summary.

Diabetes mellitus: percent of patients with a diagnosis of diabetes mellitus with blood pressure less than 140/90. This updates a previously published measure summary.

Influenza immunization: percent of applicable patients 65 years and older receiving influenza immunizations between September 1, 2007 and March 31, 2008 in accordance with defined VHA policy. This updates a previously published measure summary.

Veteran satisfaction: percent of patients reporting the overall quality of Veterans Administration (VA) ambulatory care as very good or excellent on the SHEP Outpatient Survey. This updates a previously published measure summary.

Veteran satisfaction: percent of patients reporting the overall quality of Veterans Administration (VA) inpatient care as very good or excellent on the SHEP Inpatient Survey. This updates a previously published measure summary.

April 14, 2008

Agency for Healthcare Research and Quality

Asthma admission rate (area level): rate per 100,000 population.

Decubitus ulcer: rate per 1,000 eligible admissions.

Diabetes short-term complications admission rate (area level): rate per 100,000 population.

Gastroenteritis admission rate (area level): rate per 100,000 population.

Iatrogenic pneumothorax in neonates at risk: rate per 1,000 eligible admissions.

Iatrogenic pneumothorax in non-neonates: rate per 1,000 eligible admissions.

Pediatric heart surgery mortality: number of in-hospital deaths in patients undergoing surgery for congenital heart disease per 1,000 patients.

Pediatric heart surgery: volume.

Perforated appendix admission rate (area level): number of patients admitted for perforated appendix per 100 admissions for appendicitis within an area.

Postoperative hemorrhage and hematoma: rate per 1,000 eligible admissions.

Postoperative respiratory failure: rate per 1,000 eligible admissions.

Postoperative sepsis: rate per 1,000 eligible admissions.

Postoperative wound dehiscence: number of abdominopelvic surgery patients with disruption of abdominal wall per 1,000 eligible admissions.

Selected infection due to medical care: rate per 1,000 eligible admissions.

Urinary tract infection (UTI) admission rate (area level): rate per 100,000 population.

April 7, 2008

Australian Council on Healthcare Standards

Antibiotic prophylaxis: percentage of patients who undergo hysterectomy who receive antibiotic prophylaxis prior to surgery, during the 6 month time period.

Injury to a major viscus: percentage of patients suffering injury to a major viscus with repair, during a gynaecological operative procedure or subsequently up to 2 weeks post-operatively, during the 6 month time period.

Laparoscopic management of an ectopic pregnancy: percentage of patients having laparoscopic management following an ectopic pregnancy, during the 6 month time period.

Laparoscopic surgery: percentage of patients receiving a bladder injury at the time of a laparoscopic hysterectomy with repair during the procedure or subsequently up to 2 weeks post-operatively, during the 6 month time period.

Laparoscopic surgery: percentage of patients receiving a ureter injury at the time of a laparoscopic hysterectomy with repair during the procedure or subsequently up to 2 weeks post-operatively, during the 6 month time period.

Laparoscopic surgery: percentage of patients receiving an injury to a major viscus with repair, during a laparoscopic gynaecological operative procedure or subsequently up to 2 weeks post-operatively, during the 6 month time period.

Thromboprophylaxis: percentage of moderate to high-risk patients (as per guidelines) over 40 years who undergo hysterectomy who receive thromboprophylaxis, during the 6 month time period.

Thromboprophylaxis: percentage of moderate to high-risk patients (as per guidelines) over 40 years who undergo pelvic floor surgery who receive thromboprophylaxis, during the 6 month time period.

Urogynaecology: percentage of patients receiving bladder injury at the time of a pelvic floor repair procedure with repair during the procedure or subsequently up to 2 weeks post-operatively, during the 6 month time period.

Urogynaecology: percentage of patients receiving injury to major viscus with repair, during a pelvic floor repair procedure subsequently up to 2 weeks post-operatively, during the 6 month time period.

Urogynaecology: percentage of patients receiving ureter injury at the time of a pelvic floor repair procedure with repair during the procedure or subsequently up to 2 weeks post-operatively, during the 6 month time period.

March 31, 2008

Australian Council on Healthcare Standards

Care planning: percentage of carers involved in developing care plans, during the 6 month time period.

Care planning: percentage of consumers with current completed care plans (including consumer involvement and signature) in the file, during the 6 month time period.

Community: percentage of consumers or nominated carers 3 or more face-to-face contacts within a 7 day period.

Community: percentage of consumers or nominated carers with greater than 24 treatment days over a three month period.

Community: percentage of consumers who were admitted to the hospital for psychiatric reasons (by that service) once or more in the first year of treatment.

Community: percentage of registered consumers seen face-to-face by the community service, during the 6 month time period.

Institute for Clinical Systems Improvement

Diagnosis of breast disease: percentage of class 4 or class 5 abnormal mammograms that are followed by a biopsy within 7 to 10 days. This updates a previously published measure summary.

March 24, 2008

Agency for Healthcare Research and Quality

Health plan members' experiences: percentage of parents or guardians who reported how often it was easy to get prescription medicines for their enrolled children with chronic conditions through their health plan.

Health plan members' experiences: percentage of parents or guardians who reported how often it was easy to get specialized services for their enrolled children with chronic conditions.

Health plan members' experiences: percentage of parents or guardians who reported their experiences with getting needed information about their children's care for their enrolled children with chronic conditions.

Health plan members' experiences: percentage of parents or guardians who reported their experiences with shared decision-making for their enrolled children with chronic conditions.

Health plan members' experiences: percentage of parents or guardians who reported their experiences with their children's personal doctor or nurse for their enrolled children with chronic conditions.

Health plan members' experiences: percentage of parents or guardians who reported they received assistance with coordination of care and services for their enrolled children with chronic conditions.

March 17, 2008

Physician Consortium for Performance Improvement®

Acute otitis externa (AOE): percentage of patient visits for those patients aged 2 years and older with a diagnosis of AOE with assessment for auricular or periauricular pain.

Acute otitis externa (AOE): percentage of patients aged 2 years and older with a diagnosis of AOE who were not prescribed systemic antimicrobial therapy.

Acute otitis externa (AOE): percentage of patients aged 2 years and older with a diagnosis of AOE who were prescribed topical preparations.

Otitis media with effusion (OME): percentage of patient visits for those patients aged 2 months through 12 years with a diagnosis of OME with assessment of tympanic membrane mobility with pneumatic otoscopy or tympanometry.

Otitis media with effusion (OME): percentage of patients aged 2 months through 12 years with a diagnosis of OME who received tympanostomy tube insertion who had a hearing test performed within 6 months prior to tympanostomy tube insertion.

Otitis media with effusion (OME): percentage of patients aged 2 months through 12 years with a diagnosis of OME who were not prescribed systemic antimicrobials.

Otitis media with effusion (OME): percentage of patients aged 2 months through 12 years with a diagnosis of OME who were not prescribed systemic corticosteroids.

Otitis media with effusion (OME): percentage of patients aged 2 months through 12 years with a diagnosis of OME who were not prescribed/recommended either antihistamines or decongestants.

March 10, 2008

HealthPartners

Coronary artery disease (CAD): percentage of members with CAD who have optimally managed modifiable cardiovascular risk factors (LDL cholesterol, blood pressure control, daily aspirin use, documented non-tobacco use). This updates a previously published measure summary.

Diabetes mellitus: percentage of members with diabetes (Type I and Type II) who have optimally managed modifiable cardiovascular risk factors (HbA1c, LDL cholesterol, blood pressure control, aspirin use and documented non-tobacco use). This updates a previously published measure summary.

Physician Consortium for Performance Improvement®

Emergency medicine: percentage of patients (regardless of age) with an emergency department diagnosis of acute myocardial infarction who received fibrinolytic therapy and the fibrinolytic therapy was ordered by the physician within 20 minutes of performing the 12-lead ECG.

Emergency medicine: percentage of patients (regardless of age) with an emergency department diagnosis of STEMI or new LBBB on 12-lead ECG who received primary PCI who had documentation that the emergency physician initiated communication with the cardiology intervention service within 10 minutes of the diagnostic 12-lead ECG.

Osteoporosis: percentage of patients aged 18 years and older with one of the following conditions or therapies: receiving oral glucocorticosteroid therapy for greater than 3 months OR hypogonadism OR fracture history OR transplant history OR obesity surgery OR malabsorption disease OR receiving aromatase therapy for breast cancer who had a central dual-energy X-ray absorptiometry (DXA) ordered or performed or pharmacologic therapy prescribed within 12 months.

Stroke and stroke rehabilitation: percentage of patients aged 18 years and older with the diagnosis of ischemic stroke who did not receive intravenous unfractionated heparin.

March 3, 2008

Centers for Medicare & Medicaid Services/The Joint Commission

Pneumonia: percent of patients who receive their first dose of antibiotics within 6 hours after arrival at the hospital.

Joint Commission, The

Children's asthma care: percent of pediatric asthma inpatients who received relievers during hospitalization.

Children's asthma care: percent of pediatric asthma inpatients who received systemic corticosteroids during hospitalization.

Children's asthma care: percent of pediatric asthma inpatients with documentation that they or their caregivers were given a written Home Management Plan of Care (HMPC) document.

Physician Consortium for Performance Improvement®

Anesthesiology and critical care: percentage of ICU patients aged 18 years and older who receive mechanical ventilation and who had an order on the first ventilator day for head of bed elevation (30-45 degrees).

Anesthesiology and critical care: percentage of patients who undergo central venous catheter (CVC) insertion for whom CVC was inserted with all elements of maximal sterile barrier technique followed.

Anesthesiology and critical care: percentage of patients, regardless of age, undergoing surgical or therapeutic procedures under general or neuraxial anesthesia of 60 minutes duration or longer for whom either active warming was used intraoperatively for the purpose of maintaining normothermia, OR at least one body temperature equal to or greater than 36 degrees Centigrade (or 96.8 degrees Fahrenheit) was recorded within 30 minutes immediately before or the 30 minutes immediately after anesthesia end time.

February 25, 2008

Centers for Medicare & Medicaid Services

End stage renal disease (ESRD): percentage of adult continuous ambulatory peritoneal dialysis (CAPD) patients for whom the delivered PD dose was a weekly Kt/V_urea of at least 2.0 and a weekly creatinine clearance (CrCl) of at least 60 L/week/1.73 m² or evidence that the prescription was changed according to National Kidney Foundation/Kidney Disease Outcomes Quality Initiative (NKF-K/DOQI) recommendations, during the study period. This updates a previously published measure summary.

End stage renal disease (ESRD): percentage of adult continuous cycling peritoneal dialysis (CCPD) patients for whom the delivered PD dose was a weekly Kt/V_urea of at least 2.1 and a weekly creatinine clearance (CrCl) of at least 63 L/week/1.73 m² or evidence that the prescription was changed according to National Kidney Foundation/Kidney Disease Outcomes Quality Initiative (NKF-K/DOQI) recommendations, during the study period. This updates a previously published measure summary.

End stage renal disease (ESRD): percentage of adult hemodialysis (HD) or peritoneal dialysis (PD) patients receiving Epoetin therapy with documented mean hemoglobin (Hgb) of 11-12 g/dL (110-120 g/L) during the study period. This updates a previously published measure summary.

End stage renal disease (ESRD): percentage of adult hemodialysis (HD) patients for whom delivered HD dose was calculated using formal urea kinetic modeling or Daugirdas II during the study period. This updates a previously published measure summary.

End stage renal disease (ESRD): percentage of adult hemodialysis (HD) patients whose average delivered dose of HD was a single-pool Kt/V (spKt/V) greater than or equal to 1.2 during the study period. This updates a previously published measure summary.

End stage renal disease (ESRD): percentage of adult hemodialysis (HD) patients with anemia or if prescribed Epoetin with at least one documented transferrin saturation and serum ferritin concentration result every three months. This updates a previously published measure summary.

End stage renal disease (ESRD): percentage of adult hemodialysis (HD) patients with anemia or if prescribed Epoetin with at least one documented transferrin saturation greater than or equal to 20 percent and at least one documented serum ferritin concentration greater than or equal to 100 ng/mL during a three-month period. This updates a previously published measure summary.

End stage renal disease (ESRD): percentage of adult hemodialysis (HD) patients with anemia or prescribed Epoetin with at least one transferrin saturation less than 20 percent or at least one serum ferritin concentration less than 100 ng/mL who were prescribed intravenous iron in at least one of the study months. This updates a previously published measure summary.

End stage renal disease (ESRD): percentage of adult hemodialysis (HD) patients with documented monthly adequacy measurements (urea reduction ratio [URR] or single-pool Kt/V [spKt/V]) during the study period. This updates a previously published measure summary.

End stage renal disease (ESRD): percentage of adult hemodialysis patients who were dialyzed through an arterial venous (AV) graft and whose AV graft was routinely surveyed (screened) for the presence of stenosis during the study period. This updates a previously published measure summary.

End stage renal disease (ESRD): percentage of adult nightly intermittent peritoneal dialysis (NIPD) patients for whom the delivered PD dose was a weekly Kt/V_urea of at least 2.2 and a weekly creatinine clearance (CrCl) of at least 66 L/week/1.73 m² or evidence that the prescription was changed according to National Kidney Foundation/Kidney Disease Outcomes Quality Initiative (NKF-K/DOQI) recommendations, during the study period. This updates a previously published measure summary.

End stage renal disease (ESRD): percentage of adult patients who were dialyzed with a chronic catheter continuously for 90 days or longer prior to the last hemodialysis (HD) session during the study period. This updates a previously published measure summary.

End stage renal disease (ESRD): percentage of adult peritoneal dialysis (PD) patients with anemia or if prescribed Epoetin with at least one documented transferrin saturation greater than or equal to 20 percent and at least one documented serum ferritin concentration greater than or equal to 100 ng/mL during the six-month study period. This updates a previously published measure summary.

End stage renal disease (ESRD): percentage of adult peritoneal dialysis (PD) patients with anemia or if prescribed Epoetin with at least two documented transferrin saturation and serum ferritin concentration results over the six-month study period. This updates a previously published measure summary.

End stage renal disease (ESRD): percentage of adult peritoneal dialysis (PD) patients with anemia or prescribed Epoetin with at least one transferrin saturation less than 20 percent or at least one serum ferritin concentration less than 100 ng/mL who were prescribed intravenous iron in at least one of the two-month periods during the six-month study period. This updates a previously published measure summary.

End stage renal disease (ESRD): percentage of adult peritoneal dialysis (PD) patients with total solute clearance for urea and creatinine measured at least once in a 6 month time period. This updates a previously published measure summary.

End stage renal disease (ESRD): percentage of adult peritoneal dialysis (PD) patients with weekly Kt/V_urea and creatinine clearance (CrCl) calculated in a standard way. This updates a previously published measure summary.

End stage renal disease (ESRD): percentage of incident adult hemodialysis (HD) patients who were dialyzed using an arterial venous fistula (AVF) during their last HD treatment during the study period. This updates a previously published measure summary.

End stage renal disease (ESRD): percentage of prevalent adult hemodialysis (HD) patients who were dialyzed using an arterial venous fistula (AVF) during their last HD treatment during the study period. This updates a previously published measure summary.

February 18, 2008

Child and Adolescent Health Measurement Initiative

Ask about parental concerns (developmental surveillance): proportion of children whose parents were asked by their child's health care provider if they have concerns about their child's learning, development and behavior.

Assessment of psychosocial well-being of parent(s) in the family: average percentage of recommended topics assessed.

Assessment of psychosocial well-being of parent(s) in the family: proportion of children whose parents were assessed for one or more topics related to psychosocial well-being.

Effect of care provided on parental confidence: proportion of children whose parents reported care had a positive influence on their confidence in parenting their child and managing their responsibilities.

Follow-up for children at risk for delays: proportion of children who were determined to be at significant risk for developmental, behavioral, or social delays who received some level of follow-up health care.

Health information: proportion of children whose parents received all health information.

Helpfulness of care provided to parents: proportion of children whose parents reported care provided was helpful or very helpful on core aspects of preventive and developmental health care.

Information about resources for parents in the community: proportion of parents who had their informational needs met.

Information to address parental concerns: proportion of children whose parents had concerns about their child's learning, development and behavior and they received information to address their concerns.

Preventive and developmental health care for young children: average percentage of individual care components (assessed in the Promoting Healthy Development Survey [PHDS]) a child received.

Preventive and developmental health care for young children: proportion of children who received all individual care components measures in the Promoting Healthy Development Survey (PHDS).

Standardized developmental and behavioral screening: proportion of children whose health care provider administered a parent-completed standardized developmental and behavioral screening tool.

February 11, 2008

Institute for Clinical Systems Improvement

Heart failure in adults: percentage of adult heart failure patients to whom (or to their caregivers) written or verbal instructions or educational material are given during the clinic visit, addressing one or more of the following: activity level, diet, medications, follow-up appointment, weight monitoring, and what to do if symptoms worsen (primary care and outpatient cardiology). This updates a previously published measure summary.

Heart failure in adults: percentage of adult heart failure patients who have ever had LVSD and met the following (for which they are eligible) at their last clinic visit: prescribed or were taking ACEI/ARB, prescribed or were on beta blocker therapy, non-smoker (primary care and outpatient cardiology). This updates a previously published measure summary.

Heart failure in adults: percentage of adult heart failure patients who have ever had LVSD and were prescribed or were on beta-blocker therapy within the last 12 months of the clinic visit or who have a contraindication to taking beta-blockers (primary care and outpatient cardiology).

Heart failure in adults: percentage of adult heart failure patients who have ever had LVSD and were prescribed or were taking an ACEI or ARB within the last 12 months of the clinic visit, or who have contradictions to taking both ACEI or an ARB (primary care and outpatient cardiology).

Heart failure in adults: percentage of adult heart failure patients who have not used tobacco anytime during the previous year (primary care and outpatient cardiology). This updates a previously published measure summary.

Heart failure in adults: percentage of adult heart failure patients who have used tobacco anytime during the previous year and who were given smoking cessation advice or counseling at the last clinic visit (primary care and outpatient cardiology). This updates a previously published measure summary.

Heart failure in adults: percentage of adult heart failure patients with documentation that LVS function was evaluated or will be evaluated (primary care and outpatient cardiology). This updates a previously published measure summary.

Heart failure in adults: percentage of adult patients with a primary diagnosis of heart failure discharged home with written instructions or educational material given to the patient or his or her caregiver at discharge or during the hospital stay, addressing all of the following: activity level, diet, discharge medications, follow-up appointment, weight monitoring, and what to do if symptoms worsen. This updates a previously published measure summary.

Heart failure in adults: percentage of adult patients with a primary diagnosis of heart failure who are readmitted for heart failure within 30 days of discharge. This updates a previously published measure summary.

Heart failure in adults: percentage of adult patients with a primary diagnosis of heart failure who have LVSD and who do not have a contraindication to taking beta-blockers, who are prescribed beta-blocker therapy at hospital discharge. This updates a previously published measure summary.

Heart failure in adults: percentage of adult patients with a primary diagnosis of heart failure who have LVSD and who do not have contraindications to taking both ACEI and ARBs, who are prescribed an ACEI or an ARB at hospital discharge. This updates a previously published measure summary.

Heart failure in adults: percentage of adult patients with a primary diagnosis of heart failure who have used tobacco anytime during the year prior to hospital arrival and who are given smoking cessation advice or counseling during the hospital stay or at discharge. This updates a previously published measure summary.

Heart failure in adults: percentage of adult patients with a primary diagnosis of heart failure with documentation in the hospital record that LVS function was evaluated before arrival, during hospitalization, or is planned for after discharge. This updates a previously published measure summary.

February 4, 2008

National Committee for Quality Assurance

Appropriate testing for children with pharyngitis: percentage of children 2 to 18 years of age who were diagnosed with pharyngitis, dispensed an antibiotic and received a group A streptococcus (strep) test for the episode. This updates a previously published measure summary.

Appropriate treatment for children with upper respiratory infection (URI): percentage of children 3 months to 18 years of age who were given a diagnosis of URI and were not dispensed an antibiotic prescription. This updates a previously published measure summary.

Asthma: percentage of members 5 to 56 years of age during the measurement year who were identified as having persistent asthma and who were appropriately prescribed medication during the measurement year. This updates a previously published measure summary.

Avoidance of antibiotic treatment in adults with acute bronchitis: percentage of adults 18 to 64 years of age with a diagnosis of acute bronchitis who were not dispensed an antibiotic prescription. This updates a previously published measure summary.

Breast cancer screening: percentage of women 40 to 69 years of age who had one or more mammograms during the measurement year or the year prior to the measurement year. This updates a previously published measure summary.

Cervical cancer screening: percentage of women 21 to 64 years of age who received one or more Pap tests during the measurement year or the two years prior to the measurement year. This updates a previously published measure summary.

Childhood immunization status: percentage of enrolled children who had four diphtheria, tetanus, and acellular pertussis (DTaP), three injectible polio virus (IPV), one measles-mumps-rubella (MMR), three haemophilus influenza type B (HiB), three hepatitis B, one chicken pox vaccination (VZV) and four pneumococcal conjugate vaccinations by their second birthday (combination #3). This updates a previously published measure summary.

Childhood immunization status: percentage of enrolled children who had four diphtheria, tetanus, and acellular pertussis (DTaP/DT), three injectible polio virus (IPV), one measles-mumps-rubella (MMR), three haemophilus influenza type B (HiB), three hepatitis B and one chicken pox vaccination (VZV) by their second birthday (combination #2). This updates a previously published measure summary.

Chlamydia screening: percentage of women 16 to 25 years of age who were identified as sexually active and who had at least one test for chlamydia during the measurement year. This updates a previously published measure summary.

Chronic obstructive pulmonary disease (COPD): percentage of health plan members 40 years of age and older with a new diagnosis or newly active COPD who received appropriate spirometry testing to confirm the diagnosis. This updates a previously published measure summary.

Colorectal cancer screening: percentage of adults 50 to 80 years of age who had appropriate screening for colorectal cancer. This updates a previously published measure summary.

Glaucoma screening: percentage of Medicare members 65 years and older without a prior diagnosis of glaucoma or glaucoma suspect, who received a glaucoma eye exam by an eye-care professional for the early identification of glaucomatous conditions. This updates a previously published measure summary.

Lead screening in children: percentage of children two years of age who had one or more capillary or venous lead blood tests for lead poisoning by their second birthday.

Pharmacotherapy management of COPD exacerbation: percentage of COPD exacerbations for members 40 years of age and older who had an acute inpatient discharge or ED encounter between January 1 to December 1 of the measurement year and who were dispensed a bronchodilator within 30 days of the event.

Pharmacotherapy management of COPD exacerbation: percentage of COPD exacerbations for members 40 years of age and older who had an acute inpatient discharge or ED encounter between January 1 to December 1 of the measurement year and who were dispensed a systemic corticosteroid within 14 days of the event.

January 28, 2008

Centers for Medicare & Medicaid Services

Nursing facility chronic care: percent of eligible and willing long-stay residents given the influenza vaccination during the flu season.

Nursing facility chronic care: percent of eligible and willing long-stay residents who were assessed and given pneumococcal vaccination.

Nursing facility post acute care: percent of eligible and willing short-stay residents given the influenza vaccination during the flu season.

Nursing facility post acute care: percent of eligible and willing short-stay residents who were assessed and given pneumococcal vaccination.

Institute for Clinical Systems Improvement

Immunizations: percentage of adolescents who are on time with recommended immunizations (Hep B, Hep A, HPV, MMR, MCV4, Tdap, VZV). This updates a previously published measure summary.

Immunizations: percentage of two-year olds who are on time with their primary series of immunizations (DTaP, IPV, MMR, PCV7/PPV23, VZV, Hib, Hep B, Hep A, Rota). This updates a previously published measure summary.

Immunizations: percentage of young adults who are on time with Hepatitis B (Hep B). This updates a previously published measure summary.

Preventive services for adults: percentage of patients with all Level I preventive services on time according to the guideline delivery schedule. This updates a previously published measure summary.

Preventive services for children and adolescents: the percentage of patients who are on time with recommended immunizations. This updates a previously published measure summary.

Routine prenatal care: percentage of all identified preterm birth (PTB) modifiable risk factors assessed that receive an intervention. This updates a previously published measure summary.

Routine prenatal care: percentage of pregnant women who received counseling and education by the 28th week visit. This updates a previously published measure summary.

Routine prenatal care: percentage of vaginal birth after cesarean (VBAC) eligible women who receive general education describing risks and benefits of VBAC (e.g., the American College of Obstetricians and Gynecologists [ACOG] pamphlet on VBAC). This updates a previously published measure summary.

January 21, 2008

Physician Consortium for Performance Improvement®

Melanoma: percentage of patients with a current diagnosis of melanoma or a history of melanoma who were entered into a recall system with the date for the next complete physical skin exam specified, at least once within the 12 month reporting period.

Melanoma: percentage of patients with a new diagnosis of melanoma or a history of melanoma who received all of the following aspects of care within the 12 month reporting period: (1) patient was asked about new and changing moles AND (2) patient received a complete physical skin examination AND (3) patient was counseled to perform a monthly self skin examination.

Melanoma: percentage of patients with a new occurrence of melanoma who have a treatment plan documented in the chart that was communicated to the physician(s) providing continuing care within one month of diagnosis.

Melanoma: percentage of patients with stage 0 or IA melanoma, without signs or symptoms, for whom no diagnostic imaging studies were ordered.

State of Wisconsin, Department of Health and Family Services

Obesity prevention and treatment: number of encounters with a diagnosis of obesity, morbid obesity, and overweight (MEDDIC-MS).

Obesity prevention and treatment: percent of enrollees who had a non-surgical treatment of obesity (counseling, dietary therapy, exercise program, pharmacological intervention, etc.) with a diagnosis of obesity, morbid obesity, and overweight (MEDDIC-MS).

Obesity prevention and treatment: percent of enrollees who had a screening and/or prevention encounter with a diagnosis of obesity, morbid obesity, and overweight (MEDDIC-MS).

Obesity prevention and treatment: percent of enrollees who had a surgical treatment for obesity with a diagnosis of obesity, morbid obesity, and overweight (MEDDIC-MS).

January 14, 2008

Australian Council on Healthcare Standards

Colonoscopy: percentage of incomplete colonoscopies performed, during the 6 month time period.

Colonoscopy: percentage of patients treated for possible perforation who have had a polypectomy performed, during the 6 month time period.

Complications of sedation: percentage of patients who have an endoscopy procedure involving sedation who are transferred or admitted for an overnight stay as a result of aspiration, during the 6 month time period.

Gastroscopy: percentage of patients treated for possible perforation related to oesophageal dilatation, during the 6 month time period.

Gastroscopy: percentage of patients undergoing gastroscopies (without dilations or polypectomies) who were treated for possible perforation secondary to instrument related causes, during the 6 month time period.

Gastroscopy: percentage of patients undergoing upper gastrointestinal tract polypectomies treated for possible perforation related to polypectomy, during the 6 month time period.

Monitoring of warfarin: percentage of non-same day separations receiving warfarin as an inpatient who die as a result of an adverse reaction, during the 6 month time period.

Monitoring of warfarin: percentage of non-same day separations receiving warfarin as an inpatient who experience a cerebral hemorrhage, during the 6 month time period.

Monitoring of warfarin: percentage of non-same day separations receiving warfarin as an inpatient who experience abnormal bleeding, during the 6 month time period.

Monitoring of warfarin: percentage of non-same day separations receiving warfarin as an inpatient with an international normalized ratio (INR)/prothrombin reading greater than 5, during the 6 month time period.

Monitoring of warfarin: percentage of patients on hospital initiated warfarin who receive written drug information on discharge, during the 6 month time period.

Monitoring of warfarin: percentage of patients with an international normalized ratio (INR) result above the therapeutic range who have had their dosage reviewed prior to the next warfarin administration, during the 6 month time period.

January 7, 2008

Canadian Institute for Health Information

Hip fracture: risk adjusted rate of in-hospital hip fracture among acute care inpatients aged 65 years and over, per 1,000 discharges.

Physician to population ratio: total number of general physicians and family physicians per 100,000 population.

Physician to population ratio: total number of specialist physicians per 100,000 population.

Physician Consortium for Performance Improvement®

Osteoporosis: percentage of female patients aged 65 years and older who have a central DXA measurement ordered or performed at least once since age 60 or pharmacologic therapy prescribed within 12 months.

Osteoporosis: percentage of patients aged 50 years and older treated for a hip, spine or distal radial fracture with documentation of communication with the physician managing the patient's on-going care that a fracture occurred and that the patient was or should be tested or treated for osteoporosis.

Osteoporosis: percentage of patients aged 50 years and older with a diagnosis of osteoporosis who were prescribed pharmacologic therapy within 12 months.

Osteoporosis: percentage of patients aged 50 years and older with a fracture of the hip, spine or distal radius who had a central DXA measurement ordered or performed or pharmacologic therapy prescribed.

Osteoporosis: percentage of patients, regardless of age, with a diagnosis of osteoporosis who either received both calcium and vitamin D or had documented counseling regarding both calcium and vitamin D intake, and exercise at least once within 12 months.